Resource usage among episodic migraineurs by country
| Resources used | n (%) | ||||||
|---|---|---|---|---|---|---|---|
| USA (n=226) | Canada (n=55) | France (n=109) | UK (n=107) | Germany (n=112) | Australia (n=63) | p Value* | |
| Visited a provider for HA in the last 3 months | 44 (19) | 16 (29) | 30 (27) | 28 (26) | 29 (26) | 23 (36) | 0.108 |
| Have a typical HA care provider† | 166 (73) | 44 (80) | 91 (83) | 82 (77) | 88 (79) | 50 (79) | 0.439 |
| Have visited the ED for HA | 61 (27) | 19 (35) | 15 (14) | 9 (8) | 13 (12) | 17 (27) | <0.001 |
| Have been admitted to hospital for HA | 13 (6) | 9 (16) | 13 (12) | 0 (0) | 11 (10) | 7 (11) | 0.001 |
| Number of migraine preventive agents ever tried | |||||||
| 0 | 139 (61) | 37 (67) | 62 (57) | 59 (55) | 67 (60) | 40 (63) | 0.978 |
| 1 | 40 (18) | 5 (9) | 18 (16) | 21 (20) | 20 (18) | 11 (18) | |
| 2 | 20 (9) | 6 (11) | 16 (15) | 13 (12) | 11 (10) | 4 (6) | |
| 3 | 7 (3) | 1 (2) | 4 (4) | 4 (4) | 2 (2) | 2 (3) | |
| >3 | 20 (9) | 6 (11) | 9 (8) | 10 (9) | 12 (11) | 6 (9) | |
| Number of migraine preventive agents currently used | |||||||
| 0 | 179 (79) | 41 (75) | 81 (74) | 79 (74) | 84 (75) | 48 (76) | 0.981 |
| 1 | 38 (17) | 11 (20) | 21 (19) | 24 (22) | 22 (20) | 12 (19) | |
| >1 | 9 (4) | 3 (5) | 7 (6) | 4 (4) | 6 (5) | 3 (5) | |
| Type of migraine preventive agent(s) currently used‡ | |||||||
| Antidepressant | 32 (14) | 9 (16) | 17 (16) | 17 (16) | 15 (13) | 11 (17) | N/A |
| Antiepileptic | 13 (6) | 4 (7) | 6 (5) | 3 (3) | 1 (1) | 2 (3) | |
| β Blocker | 8 (3) | 4 (7) | 11 (10) | 10 (9) | 18 (16) | 3 (5) | |
| Calcium channel blocker | 4 (2) | 0 (0) | 2 (2) | 2 (2) | 3 (3) | 1 (2) | |
| Number of migraine acute agents ever tried | |||||||
| ≤3 | 62 (27) | 17 (31) | 16 (15) | 22 (21) | 21 (19) | 14 (22) | 0.067 |
| >3 | 164 (73) | 38 (69) | 93 (85) | 85 (79) | 91 (81) | 49 (78) | |
| Type of migraine acute agent(s) currently used‡ | |||||||
| Prescription | 106 (47) | 24 (44) | 68 (62) | 76 (71) | 68 (61) | 35 (56) | N/A |
| OTC | 192 (85) | 53 (96) | 81 (74) | 78 (73) | 82 (73) | 54 (86) | |
*p Values from χ2 tests.
†Subjects who report that they have a healthcare provider who they typically visit for headache-related care.
‡Subjects may be using more than one agent.
ED, emergency department; HA, headache; N/A, not available (some respondents taking more than one agent); OTC, over the counter.